IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CRIMINI, EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.013
AS - Asia 1.817
NA - Nord America 1.665
SA - Sud America 174
Continente sconosciuto - Info sul continente non disponibili 174
AF - Africa 40
OC - Oceania 14
Totale 5.897
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.570
DE - Germania 966
CN - Cina 502
SG - Singapore 486
IT - Italia 364
BD - Bangladesh 195
HK - Hong Kong 193
SE - Svezia 162
VN - Vietnam 146
BR - Brasile 127
IN - India 125
FR - Francia 115
RU - Federazione Russa 98
GB - Regno Unito 88
NL - Olanda 57
CA - Canada 48
FI - Finlandia 45
JP - Giappone 29
IE - Irlanda 28
TR - Turchia 25
ID - Indonesia 24
MX - Messico 23
ES - Italia 20
PL - Polonia 16
KR - Corea 15
CI - Costa d'Avorio 13
AT - Austria 12
CO - Colombia 12
AU - Australia 11
EG - Egitto 9
AR - Argentina 8
LB - Libano 8
PK - Pakistan 8
JM - Giamaica 7
PH - Filippine 7
SA - Arabia Saudita 7
TW - Taiwan 7
UZ - Uzbekistan 7
VE - Venezuela 7
BE - Belgio 6
EC - Ecuador 6
IQ - Iraq 6
CH - Svizzera 5
CL - Cile 5
PE - Perù 5
UA - Ucraina 5
CR - Costa Rica 4
MY - Malesia 4
RO - Romania 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
GR - Grecia 3
HU - Ungheria 3
IR - Iran 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
SD - Sudan 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
OM - Oman 2
PA - Panama 2
SC - Seychelles 2
TN - Tunisia 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
GT - Guatemala 1
IL - Israele 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MQ - Martinica 1
MT - Malta 1
NO - Norvegia 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 5.724
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 906
Ashburn 298
Singapore 222
Hong Kong 164
San Jose 147
Santa Clara 138
Council Bluffs 101
Hefei 86
Dallas 81
Beijing 77
Milan 76
Los Angeles 61
New York 56
Chandler 54
Boardman 44
Hanoi 40
Bengaluru 38
Helsinki 35
Lauterbourg 34
Ho Chi Minh City 32
Buffalo 30
Moscow 27
Southend 27
Rome 25
Dublin 24
Shanghai 23
Hyderabad 22
Naples 18
Tokyo 18
Chennai 17
Jakarta 16
Guangzhou 15
London 15
Princeton 15
Florence 14
São Paulo 14
Abidjan 13
Istanbul 13
Boston 12
Chicago 12
Munich 12
Düsseldorf 11
Nuremberg 10
Seoul 10
Bologna 9
Phoenix 9
Barcelona 8
Cairo 8
Cangzhou 8
Da Nang 8
Des Moines 8
Fuzhou 8
Gdansk 8
Paris 8
Toronto 8
Turin 8
Warsaw 8
Washington 8
Atlanta 7
Brooklyn 7
Cambridge 7
Lappeenranta 7
Mexico City 7
Oklahoma City 7
Orem 7
Ann Arbor 6
Bari 6
Houston 6
Madrid 6
Palermo 6
Seattle 6
Tashkent 6
Valencia 6
Bexley 5
Bogotá 5
Brussels 5
Charlotte 5
Columbus 5
Duluth 5
Lanester 5
Montreal 5
Roubaix 5
Shenzhen 5
Sydney 5
The Dalles 5
Bergamo 4
Berlin 4
Brasília 4
Calgary 4
Can Tho 4
Cuauhtémoc 4
Denver 4
Dong Ket 4
Hangzhou 4
Kingston 4
Manchester 4
Miano 4
Nanjing 4
New Delhi 4
Piscataway 4
Totale 3.434
Salva come PNG Salva come JPEG
Nome #
Margetuximab for the treatment of HER2-positive metastatic breast cancer 549
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer 299
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents 286
The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population 257
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 254
Safety of covid-19 mrna vaccines in patients with cancer enrolled in early-phase clinical trials 215
Precision medicine in breast cancer : From clinical trials to clinical practice 209
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations 203
First line treatment of BRAF mutated advanced melanoma: Does one size fit all? 198
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population 198
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions 190
Adjuvant treatment of early male breast cancer 183
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation? 175
Clinical development and current role of margetuximab for the treatment of breast cancer 171
Characterization of low HER2 expressions in de-novo metastatic breast cancer 169
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience 165
Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy 164
Molecular tumor board in patients with metastatic breast cancer 153
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 152
COVID-19 related risk in patients enrolled in early-phase clinical trials 151
Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis 141
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population 132
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis 125
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience 124
The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit 124
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology 116
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running? 113
SARS-CoV-2 vaccines for cancer patients: a call to action 110
Predicting Response to Antibody Drug Conjugates: A Focus on Antigens’ Targetability 108
Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go? 102
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers 95
PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative 91
Molecular tumour board in gastrointestinal cancers 21
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial 19
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial 16
The role of the molecular tumor board: learnings from the ROME trial 14
Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions 14
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards 14
Unfavorable carcinoma of unknown primary with a gastrointestinal profile: a retrospective study 14
Fast Mimicking Diets and Other Innovative Nutritional Interventions to Treat Patients with Breast Cancer 11
The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046 10
Beyond PD(L)-1 blockade in microsatellite-instable cancers: current landscape of immune co-inhibitory receptor targeting 10
A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing data 9
Variant allele frequency: a decision-making tool in precision oncology? 9
Targeting cellular components of the tumor microenvironment in solid malignancies 8
null 6
Totale 5.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022159 0 8 9 10 9 9 1 22 29 19 23 20
2022/2023320 26 33 42 21 42 42 5 13 39 16 28 13
2023/20241.000 29 30 22 48 94 59 150 117 64 104 144 139
2024/20251.294 116 147 116 121 87 49 19 126 78 116 125 194
2025/20262.667 324 260 266 210 155 86 325 88 230 162 305 256
2026/2027400 161 239 0 0 0 0 0 0 0 0 0 0
Totale 5.897